Cite

    Radujkovic, A., Dietrich, S., Andrulis, M., Benner, A., Longerich, T., Pellagatti, A., Nanda, K., Giese, T., Germing, U., Baldus, S., Boultwood, J., Ho, A. D., Dreger, P., & Luft, T. (n.d.). expression of CDKN1C in the bone marrow of patients with myelodysplastic syndrome and secondary acute myeloid leukemia is associated with poor survival after conventional chemotherapy. International journal of cancer, 139(6), 1402–1413. http://access.bl.uk/ark:/81055/vdc_100034747801.0x00002e